comprehensive -WSS

comprehensive

author：explore 2025-10-02 17:21:46 - browse：9852

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Exact Sciences stock tumbles despite strong cancer detection sales

WSS

EPA limits use of carcinogenic gas for sterilizing medical devices

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Q&A: Jennifer Adair on making gene therapy available globally

Readout Newsletter: CAR

H5N1 bird flu found in pasteurized milk: what we know

Cue Health's Covid

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Key Senate committee drafts bipartisan bill to stem drug shortages

At least 13 dead in Texas as scorching temps continue

Q&A: Jennifer Adair on making gene therapy available globally

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Supreme Court strikes down use of affirmative action

H5N1 bird flu virus started spreading in cows in Texas in December

Medicare proposal to cover medical devices draws a mixed reaction

Why depression after traumatic brain injury is distinct

Wikipedia

First U.S. drug developed to treat liver disease MASH is approved

Why rehabilitation engineers need to center patients in their research

As AI in medicine takes off, can 'human in the loop' prevent harm?

Medicare coverage of Wegovy, once blocked, now looks possible

Melinda French Gates resigns from Gates Foundation

MassMutual is introducing free genetic testing for members

Wikipedia

focus

focus

focus